Report Overview

The EU Contraceptives market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 7.76% during the forecast period

Using contraceptives is an effective method to keep population growth in check. Unintended pregnancies which were traditionally avoided by abortions are now being evaded with the use of contraceptives. Contraceptives are extremely effective in evading the occurrence of STIs. Along with being safe and reliable, contraceptives also show a high success rate. Thus, owing to the various benefits of contraceptives, the contraceptive market has shown immense progress in the EU market. It is estimated that among the EU women, meeting the needs of family planning is estimated to be as high as 10.1%. Contribution toward the growth of the contraceptives market is a necessity in order to avoid unwanted pregnancies and their complications. A high percentage of women who are sexually active do not want to become pregnant. The contraceptive prevalence in the EU is estimated to be 71.8%, indicating a good use of contraceptives among the EU population



Market Growth Drivers

Certain factors that are driving the market growth include the increasing prevalence of STDs, the growing rate of unintended pregnancies, increasing demand for modern contraceptive methods, and rising government initiatives. However, factors, such as religious and cultural opposition in certain emerging nations have been restraining the growth of this market. Along with this, the fear of certain side effects and issues, such as infertility resulting from the use of contraceptives have been major setbacks from the market point of view